BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37200061)

  • 1. Shelter from the cytokine storm in myelofibrosis.
    Lane SW
    Blood; 2023 May; 141(20):2415-2416. PubMed ID: 37200061
    [No Abstract]   [Full Text] [Related]  

  • 2. Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis.
    Koschmieder S; Jost E; Cornelissen C; Müller T; Schulze-Hagen M; Bickenbach J; Marx G; Kleines M; Marx N; Brümmendorf TH; Dreher M
    Eur J Haematol; 2020 Nov; 105(5):655-658. PubMed ID: 32593209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID-19 Cytokine Storm.
    Meng QF; Tian R; Long H; Wu X; Lai J; Zharkova O; Wang JW; Chen X; Rao L
    Adv Mater; 2021 May; 33(20):e2100012. PubMed ID: 33837596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm.
    Yang X; You J; Wei Y; Li H; Gao L; Guo Q; Huang Y; Gong C; Yi C
    J Mater Chem B; 2021 Oct; 9(39):8185-8201. PubMed ID: 34528037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine storm and translating IL-6 biology into effective treatments for COVID-19.
    Li T; Wang D; Wei H; Xu X
    Front Med; 2023 Dec; 17(6):1080-1095. PubMed ID: 38157195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
    Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
    J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
    Machado C; González-Quevedo A
    MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells.
    Hafezi B; Chan L; Knapp JP; Karimi N; Alizadeh K; Mehrani Y; Bridle BW; Karimi K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.
    Muhammad A; Forcados GE; Sani H; Ndidi US; Adamu A; Katsayal BS; Sadiq IZ; Abubakar YS; Sulaiman I; Abubakar IB; Yusuf AP; Malami I; Ibrahim S; Abubakar MB
    J Food Biochem; 2022 May; 46(5):e14079. PubMed ID: 35060145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.
    Zanza C; Romenskaya T; Manetti AC; Franceschi F; La Russa R; Bertozzi G; Maiese A; Savioli G; Volonnino G; Longhitano Y
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy Between Cytokines and Risk Factors in the Cytokine Storm of COVID-19: Does Ongoing Use of Cytokine Inhibitors Have a Protective Effect?
    Miossec P
    Arthritis Rheumatol; 2020 Dec; 72(12):1963-1966. PubMed ID: 32725790
    [No Abstract]   [Full Text] [Related]  

  • 13. Attenuation of COVID-19-induced cytokine storm in a young male patient with severe respiratory and neurological symptoms.
    Muschitz C; Trummert A; Berent T; Laimer N; Knoblich L; Bodlaj G; Krainer A; Linder C; Resch H
    Wien Klin Wochenschr; 2021 Sep; 133(17-18):973-978. PubMed ID: 33905029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
    Pum A; Ennemoser M; Adage T; Kungl AJ
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID 19: in the eye of the cytokine storm.
    Liuzzo G; Patrono C
    Eur Heart J; 2021 Jan; 42(2):150-151. PubMed ID: 33462598
    [No Abstract]   [Full Text] [Related]  

  • 16. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
    Liu JM; Chi J
    Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming Growth Factor-β1 C (+869) T Codon 10 Gene Polymorphism Significantly Associated with Rates of SARS-CoV-2 in Kidney Transplant Recipients in Kuwait.
    Jahromi M; Al Otaibi T; Othman N; Mahmoud T; Nair P; Halim MA; Gheith O
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):299-309. PubMed ID: 38385416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calming the cytokine storm in COVID-19.
    Cron RQ; Caricchio R; Chatham WW
    Nat Med; 2021 Oct; 27(10):1674-1675. PubMed ID: 34480126
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of the cytokine storm in COVID-19.
    Wright DJM
    Lancet Infect Dis; 2021 Jan; 21(1):25-26. PubMed ID: 32386610
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokine Storm.
    Mudd PA; Crawford JC; Thomas PG
    N Engl J Med; 2021 Apr; 384(16):e59. PubMed ID: 33882216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.